These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3111140)
41. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation. Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253 [TBL] [Abstract][Full Text] [Related]
42. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. Cunningham D; Paz-Ares L; Milan S; Powles R; Nicolson M; Hickish T; Selby P; Treleavan J; Viner C; Malpas J J Clin Oncol; 1994 Apr; 12(4):759-63. PubMed ID: 8151319 [TBL] [Abstract][Full Text] [Related]
43. Autologous stem-cell transplantation in multiple myeloma. Gahrton G Wien Med Wochenschr; 1995; 145(2-3):52-4. PubMed ID: 7762254 [TBL] [Abstract][Full Text] [Related]
44. Long-term complete remission after allogeneic bone marrow transplantation in multiple myeloma. Angelucci E; Baronciani D; Lucarelli G; Galimberti M; Polchi P; Filippetti A; Filocamo M; Donati M Bone Marrow Transplant; 1991 Oct; 8(4):307-9. PubMed ID: 1756328 [TBL] [Abstract][Full Text] [Related]
45. Successful T cell-depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmacytomas. Or R; Mehta J; Naparstek E; Okon E; Cividalli G; Slavin S Bone Marrow Transplant; 1992 Oct; 10(4):381-2. PubMed ID: 1422496 [TBL] [Abstract][Full Text] [Related]
46. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Novitzky N; Mohamed R Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962 [TBL] [Abstract][Full Text] [Related]
47. Allogeneic bone marrow transplantation in multiple myeloma. Tura S; Cavo M Hematol Oncol Clin North Am; 1992 Apr; 6(2):425-35. PubMed ID: 1582983 [TBL] [Abstract][Full Text] [Related]
48. Long-term complete remission in IgD-myeloma. Bemelmans RH; van Toorn DW; van Leeuwen L; Schaar CG Eur J Haematol; 2006 Apr; 76(4):339-41. PubMed ID: 16519706 [TBL] [Abstract][Full Text] [Related]
49. [Complete remission in multiple myeloma with natural interferon-alpha (HLBI) and melphalan/prednisolone intermittent therapy]. Ito M; Nakagawa T; Imoto S; Isobe T; Nakao Y Rinsho Ketsueki; 1990 Jun; 31(6):847-52. PubMed ID: 2214176 [TBL] [Abstract][Full Text] [Related]
50. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. Corradini P; Voena C; Tarella C; Astolfi M; Ladetto M; Palumbo A; Van Lint MT; Bacigalupo A; Santoro A; Musso M; Majolino I; Boccadoro M; Pileri A J Clin Oncol; 1999 Jan; 17(1):208-15. PubMed ID: 10458235 [TBL] [Abstract][Full Text] [Related]
51. [Recent progress in the treatment of hematological malignancies. V. Therapy of multiple myeloma]. Imamura Y Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):809-13. PubMed ID: 2677178 [No Abstract] [Full Text] [Related]
52. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. Löwenberg B; Verdonck LJ; Dekker AW; Willemze R; Zwaan FE; de Planque M; Abels J; Sonneveld P; van der Lelie J; Goudsmit R J Clin Oncol; 1990 Feb; 8(2):287-94. PubMed ID: 2405106 [TBL] [Abstract][Full Text] [Related]
54. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [TBL] [Abstract][Full Text] [Related]
55. Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma. Kröger N; Badbaran A; Zabelina T; Ayuk F; Wolschke C; Alchalby H; Klyuchnikov E; Atanackovic D; Schilling G; Hansen T; Schwarz S; Heinzelmann M; Zeschke S; Bacher U; Stübig T; Fehse B; Zander AR Biol Blood Marrow Transplant; 2013 Mar; 19(3):398-404. PubMed ID: 23078786 [TBL] [Abstract][Full Text] [Related]
56. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse. Choi SJ; Lee JH; Lee JH; Kim S; Seol M; Lee YS; Lee JS; Kim WK; Chi HS; Lee KH Leukemia; 2004 Nov; 18(11):1789-97. PubMed ID: 15385924 [TBL] [Abstract][Full Text] [Related]
57. A patient with progressive multiple myeloma treated successfully with arsenic trioxide after allogeneic bone marrow transplantation. Gesundheit B; Shapira MY; Ackerstein A; Resnik IB; Bitan M; Or R Acta Haematol; 2007; 117(2):119-21. PubMed ID: 17135719 [TBL] [Abstract][Full Text] [Related]
58. Bone marrow transplant and pediatric multiple myeloma. Davidow KA; Walter AW; Kolb EA Pediatr Blood Cancer; 2019 Feb; 66(2):e27528. PubMed ID: 30393949 [TBL] [Abstract][Full Text] [Related]
59. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. Sebban C; Lepage E; Vernant JP; Gluckman E; Attal M; Reiffers J; Sutton L; Racadot E; Michallet M; Maraninchi D J Clin Oncol; 1994 Dec; 12(12):2580-7. PubMed ID: 7989932 [TBL] [Abstract][Full Text] [Related]
60. Transfusion management of an IgA deficient patient with anti-IgA and incidental correction of IgA deficiency after allogeneic bone marrow transplantation. Rogers RL; Javed TA; Ross RE; Virella G; Stuart RK; Frei-Lahr D Am J Hematol; 1998 Apr; 57(4):326-30. PubMed ID: 9544978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]